Status:
UNKNOWN
Lifemel Honey to Reduce Leucopenia During Chemotherapy
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Zuf Globus Laboratories Ltd.
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
This study will include 60 patients with early breast cancer referred to receive adjuvant chemotherapy with AC ( adriamycin- cyclophosphamide) or CAF ( adriamycin- cyclophosphamide- 5- fluorouracil ) ...
Eligibility Criteria
Inclusion
- breast cancer patient treated with adjuvant chemotherapy
- PS = 2 or less
Exclusion
- none
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00243165
Start Date
November 1 2005
Last Update
December 7 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.